Clinical Trial Update: Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating lenalidomide with alvocidib in relapsed or refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Lymphocytic Leukemia
• Prolymphocytic Leukemia
• Small Lymphocytic Lymphoma
• Thrombocytopenia

Drugs mentioned

• Alvocidib (Flavopiridol) (alvocidib)
• Revlimid (lenalidomide) (lenalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Anemia, Chronic Lymphocytic Leukemia | Phase 1 | Status: COMPLETED